-
A simple, safe, one-a-day capsule of omega-3 polyunsaturated fatty acids (PUFA) can reduce mortality and admission to hospital for cardiovascular reasons in patients with heart failure. These are the conclusions of the first of two Articles based on the GISSI-HF* study published early Online and in an upcoming edition of ...
-
Use of the heart-rate lowering drug ivabradine can reduce the incidence of cardiovascular disease and death in patients with coronary artery disease and a high heart rate. These are the conclusions of the first of two Articles (the BEAUTIFUL study) published early Online and in an upcoming edition of The ...
-
The angiotensin-receptor blocker (ARB) telmisartan should be regarded as a potential treatment for vascular disease or high-risk diabetes, in the 20% of patients who are unable to tolerate the standard treatment of angiotensin-converting enzyme (ACE) inhibitors....
-
Acuson SC2000 is the world's first echocardiography system to acquire instantaneous, nonstitched full-volume images of the heart in a single heartbeat. Siemens Healthcare unveils the Acuson SC2000 volume imaging ultrasound system, the first system in the world to acquire non-stitched real-time full-volume 3D images of the heart in one single ...
-
In patients with diabetes, the CYPHER® Sirolimus-eluting Coronary Stent outperformed the Taxus® Stent with significantly lower rates of in-segment restenosis (a reblockage within the stented area), target lesion revascularization (TLR; the need for another interventional procedure) and major adverse events (MACE, a composite of death, heart attack and TLR) at ...
-
Instrumentation Laboratory (IL) announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance to expand the intended use for the HemosIL D-Dimer assay to exclude venous thromboembolism (VTE) in outpatients suspected of deep venous thrombosis (DVT) and pulmonary embolism (PE), when used in conjunction with a clinical ...
-
Statins, a group of drugs used to lower cholesterol levels in people with or at risk of having cardiovascular disease, should be used more frequently to combat the adverse cardiovascular outcomes from atherosclerosis, according to new research published in the September 2008 issue of the Journal of Vascular Surgery....
-
The Vascular Medtronic Talent Thoracic Stent Graft™ System (VALOR) is a safe and effective endovascular therapy, as an alternative to open surgery in patients with thoracic aortic aneurysms who were considered candidates for open surgical repair, according to research published in the September 2008 Journal of Vascular Surgery, published by ...
-
In patients with diabetes, the CYPHER® Sirolimus-eluting Coronary Stent outperformed the Taxus® Stent with significantly lower rates of in-segment restenosis (a reblockage within the stented area), target lesion revascularization (TLR; the need for another interventional procedure) and major adverse events (MACE, a composite of death, heart attack and TLR) at ...
-
An international study, led by the University of Edinburgh, raises concerns that some patients may not be receiving the optimum medical treatment and follow-up care because doctors are misjudging the risk of a further heart attack. Researchers looked at data taken from the Global Registry of Coronary Events that included ...
-
The Endocrine Society has released a new clinical practice guideline for the detection, diagnosis, and treatment of patients with primary aldosteronism. The guidelines appear in the September issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society. Primary aldosteronism (PA) refers to conditions in ...
-
Cook Medical announced a significant milestone for its EVOLUTION® Mechanical Dilator Sheath technology, an innovative new tool designed to remove faulty, ineffective leads in patients with cardiac pacemakers. To date, 200 medical centers in the United States have adopted the breakthrough technology that utilizes venous entry during pacemaker lead extraction ...
-
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members. "We strongly recommend restrictions in the use of thiazolidinediones (the class of drugs) and question ...
-
Researchers at The University of Nottingham have been awarded £2.8 million by the Wellcome Trust to develop a new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers. In the UK, 2.6 million people suffer from heart disease and ...
-
The American Society of Nuclear Cardiology (http://www.asnc.org) will be pleased to host its Annual Scientific Session from September 10 - 14, 2008 in Boston, MA. Imaging specialists from around the globe will gather at ASNC2008 to discuss the meeting's theme -- "Imaging for Primary and Secondary Prevention: Improving the Detection ...
-
BIOTRONIK announced the enrollment of the first patient into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) study. Drs William T. Abraham and Ralph Augostini at The Ohio State University Medical Center in Columbus, Ohio, USA, enrolled and implanted the Lumax HF-T CRT-D device in the first patients in EchoCRT....
-
The Children's Hospital at Montefiore (CHAM) is bringing the medical miracle of pediatric heart transplantation to the Bronx, following the recent approval of its transplant center application by the New York State Department of Health. This important approval clears the way for specialists at CHAM, recently ranked among America's top ...
-
Scientists at the National Cancer Institute in the US say more research is needed into the effects of low-dose radiation on cardiovascular risk, an area that remains controversial and about which there is too much uncertainty to give reliable estimates of numbers affected, compared to the well documented risks of ...
-
AstraZeneca welcomes the recommendations by the National Institute for Health and Clinical Excellence (NICE) on the treatment of Familial Hypercholesterolaemia (FH) 1, a genetic condition resulting in high cholesterol levels. As part of its comprehensive review on the identification and management of people with FH, NICE has recommended that adults ...
-
Stereotaxis, Inc. (Nasdaq: STXS), announced that it has received regulatory clearance from the U.S. Food and Drug Administration for its magnetically tipped, PowerAssert(TM) radiofrequency (RF) guidewire to cross chronic total occlusions in the peripheral vasculature....
